H. A. Öztürk, M. Albayrak, Ç. Pala, S. Maral, A. Yıldız, O. Şahin, Pınar Cömert
{"title":"慢性淋巴细胞白血病患者的临床病程、预后特征和治疗反应的评估:单中心经验","authors":"H. A. Öztürk, M. Albayrak, Ç. Pala, S. Maral, A. Yıldız, O. Şahin, Pınar Cömert","doi":"10.5505/aot.2019.41033","DOIUrl":null,"url":null,"abstract":"INTRODUCTION: We aimed to assess patients with chronic lymphocytic leukemia (CLL) with respect to their general clinical features, first-line treatments, survival time, and factors affecting treatment response. METHODS: This study retrospectively enrolled 169 patients with available medical records of 188 patients who were under follow-up with CLL at Training and Research Hospital, Department of Hematology between","PeriodicalId":435847,"journal":{"name":"Acta Oncologica Turcica","volume":"36 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Assessment of Clinical Course, Prognostic Features, and Treatment Response of Patients with Chronic Lymphocytic Leukemia: A Single Center Experience\",\"authors\":\"H. A. Öztürk, M. Albayrak, Ç. Pala, S. Maral, A. Yıldız, O. Şahin, Pınar Cömert\",\"doi\":\"10.5505/aot.2019.41033\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"INTRODUCTION: We aimed to assess patients with chronic lymphocytic leukemia (CLL) with respect to their general clinical features, first-line treatments, survival time, and factors affecting treatment response. METHODS: This study retrospectively enrolled 169 patients with available medical records of 188 patients who were under follow-up with CLL at Training and Research Hospital, Department of Hematology between\",\"PeriodicalId\":435847,\"journal\":{\"name\":\"Acta Oncologica Turcica\",\"volume\":\"36 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Oncologica Turcica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5505/aot.2019.41033\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Oncologica Turcica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5505/aot.2019.41033","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Assessment of Clinical Course, Prognostic Features, and Treatment Response of Patients with Chronic Lymphocytic Leukemia: A Single Center Experience
INTRODUCTION: We aimed to assess patients with chronic lymphocytic leukemia (CLL) with respect to their general clinical features, first-line treatments, survival time, and factors affecting treatment response. METHODS: This study retrospectively enrolled 169 patients with available medical records of 188 patients who were under follow-up with CLL at Training and Research Hospital, Department of Hematology between